ADHD Medications

The FDA warns that a class of medications used to treat attention deficit hyperactivity disorder (ADHD) can cause painful and prolonged erections known as priapism. Without immediate medical intervention, priapism can permanently damage the penis. The FDA has required updated drug labels and patient medication guides to warn of this serious risk associated with drugs containing methylphenidate hydrochloride and dexmethylphenidate hydrochloride.

Methylphenidate products marketed in the US include:

• Concerta® • Daytrana® • Focalin® • Focalin XR® • Metadate CD® • Metadate ER® • Methylin® • Methylin ER® • Quillivant XR® • Ritalin® • Ritalin LA® • Ritalin SR®

Another ADHD drug, Strattera® (atomoxetine), has also been associated with priapism. A vast majority of the reported cases of priapism involved patients younger than 18. In 2012, 3.9 million patients – over 60% of whom were male – received prescriptions for methylphenidate or dexmethylphenidate drugs. Adolescents are often reluctant to report priapism: young men and boys may not recognize the problem or may feel too embarrassed to tell anyone if it occurs.

Some patients required hospitalization, and the most severe cases necessitated surgical intervention (shunt placement and needle aspiration of the penis). A few reported cases of priapism occurred following the withdrawal of ADHD medication use, including drug discontinuation and inconsistent dosing.

The FDA recommends seeking immediate medical treatment for symptoms such as abnormally long-lasting or painful erections.

If you or a loved one has experienced priapism from ADHD medication, we encourage you to fill out our contact form or call us at 1-800-644-1734 for a free case evaluation.

Have a Question?

Please Contact Us using our Contact page
or by calling Toll-Free: (800) 664-1734

Related to ADHD

Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

The FDA warns that a class of medications used to treat attention deficit hyperactivity disorder (AD[...]

Recent Posts about Drugs and Pharmaceuticals

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY In October[...]
Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Springfield, Mass. - Yesterday, Federal Bankruptcy Judge Henry Boroff ruled in open court confirming[...]
Federal Jury Awards over $9 Billion in Actos Trial

Federal Jury Awards over $9 Billion in Actos Trial

On Monday, a jury in Louisiana awarded Terrence and Susan Allen over $9 Billion (that’s right: $9,[...]
No thumbnail available

FDA Uncovers Wide-Spread Contamination in Weight Loss Products

The FDA has launched an investigation of weight loss products contaminated with undeclared chemica[...]
No thumbnail available

Male Testosterone Supplements Linked to Increased Risk of Heart Attack & Stroke

Abbott Labs is under fire after several users of its Androgel® testosterone replacement drug cla[...]
Unexpected Breast Growth from Risperdal Traumatizes Young Men

Unexpected Breast Growth from Risperdal Traumatizes Young Men

Just before the first trial involving Risperdal® (Risperidone) began in Pennsylvania state court[...]
Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

The FDA warns that a class of medications used to treat attention deficit hyperactivity disorder (AD[...]
No thumbnail available

Andrews Thornton Higgins Razmara Hand-Delivers NECC Bankruptcy Claims

In order to guarantee proper and timely filing of over 150 claims in the New England Compounding[...]